Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01550094
Other study ID # 2011.191.B
Secondary ID 2011.191.B
Status Completed
Phase N/A
First received March 7, 2012
Last updated October 13, 2015
Start date March 2012
Est. completion date October 2015

Study information

Verified date October 2015
Source Ochsner Health System
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

One technique for the nerve block involves injecting the numbing medicine where the nerve is together (higher up in the back of the thigh). The other technique involves injecting the numbing medicine where the nerve splits into two parts. By injecting numbing medication around the nerve(s), there will be less pain after the procedure. It is thought that the numbing medicine will be easier to inject in the group that the nerves are split. It is expected that subjects may need less pain medication and have lower pain ratings in this group too.


Description:

The purpose of this study is to compare two different techniques for placement of nerve blocks for your foot or ankle procedure. A nerve block involves injecting numbing medications around a nerve to decrease pain after surgery. An ultrasound machine is often used to help see the nerve before injecting the numbing medicine. When an ultrasound machine is used during a block it is called an ultrasound-guided block.

Many studies of ultrasound-guided nerve blocks have involved mostly thin patients, especially from foreign countries. This study is different because the investigators are looking at patients living in America with a body mass index (a measure of the amount of body fat a person has) of more than 35.

The Sciatic nerve is a large nerve that provides most of the feeling and all of the movement to the foot and ankle. The nerve travels under the back of the leg, and splits into two smaller nerves slightly above the knee.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients = 18 years of age undergoing unilateral foot and/or ankle surgery

- Severe or morbid obesity, defined as a BMI of 35-39 or = 40, respectively

- ASA status I-IV

- Ability to understand and provide informed consent

Exclusion Criteria:

- True allergy, not sensitivity, to any of the following substances:

Local Anesthetics Midazolam Fentanyl Hydromorphone Propofol

- Pregnancy

- Evidence of infection at or near the proposed needle insertion site

- Unstable or undetermined neurologic disease of the lower extremity

- Chronic pain patients

- Patient refusal or inability to provide informed consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Ochsner Clinic Foundation New Orleans Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Jose Soberon, MD

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01542840 - Onset Time of Nerve Block: A Comparison of Two Injection Locations in Patients Having Lower Leg/ Foot Surgery N/A